18 Results

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Tallman
    Tallman
  3. Levine
    Levine
  4. Gonen
    Gonen
  5. Patel
    Patel
  6. Roshal
    Roshal
  7. Stein
    Stein
  8. Derkach
    Derkach
  9. Famulare
    Famulare
  10. Glass
    Glass

Groups

  1. Adult Leukemia (18)
  2. Biostatistics Service (18)
  3. Center for Hematologic Malignancies (18)
  4. Department of Medicine (18)
  5. Epidemiology and Biostatistics (18)
  6. Executive Committee, Center for Hematologic Malignancies (18)
  7. GSK Faculty (18)
  8. Hematologic Malignancies, Division of (18)
  9. Human Oncology and Pathogenesis Program (18)
  10. Tow Center for Developmental Oncology (TCDO) (18)
  1. "Omar Abdel-Wahab"
  2. "Martin Tallman"
  3. "Biostatistics Service"
  4. "Center for Hematologic Malignancies"
  5. "Ross Levine"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (7)
Groups
  1. Adult Leukemia (18)
  2. Biostatistics Service (18)
  3. Center for Hematologic Malignancies (18)
  4. Department of Medicine (18)
  5. Epidemiology and Biostatistics (18)
  6. Executive Committee, Center for Hematologic Malignancies (18)

More Groups

People
  1. Martin Tallman (18)
  2. Omar Abdel-Wahab (18)
  3. Ross Levine (18)
  4. Mithat Gonen (10)
  5. Jay Patel (7)
  6. Eytan Stein (6)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (2)
  5. 2016 (1)
  6. 2015 (3)

More Years

Publications
  1. Blood (7)
  2. Blood Advances (2)
  3. Leukemia Research (2)
  4. New England Journal of Medicine (2)
  5. American Journal of Hematology (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Nature Publishing Group (3)
  3. Elsevier Ltd (2)
  4. Massachusetts Medical Society (2)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons, Inc. (1)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
    Journal Article

    Ganzel, C.; Sun, Z.; Baslan, T.; Zhang, Y.; Gönen, M.; Abdel-Wahab, O. I.; Racevskis, J.; Garrett-Bakelman, F.; Lowe, S. W.; Fernandez, H. F.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
    Journal Article

    Guryanova, O. A.; Shank, K.; Spitzer, B.; Luciani, L.; Koche, R. P.; Garrett-Bakelman, F. E.; Ganzel, C.; Durham, B. H.; Mohanty, A.; Hoermann, G.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • DNMT3A R882 mutation promote chemoresistance and therapeutic relapse through impaired DNA-damage sensing
    Meeting Abstract

    Guryanova, O.; Shank, K.; Garrett-Bakelman, F.; Spitzer, B.; Ganzel, C.; Rapaport, F.; Keller, M.; Evangelista, L.; Glass, J.; Rowe, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save